163 related articles for article (PubMed ID: 25489005)
1. Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: a case report and review of literature.
Takada S; Hoshino Y; Ito H; Masugi Y; Terauchi T; Endo K; Kimata M; Furukawa J; Shinozaki H; Kobayashi K; Ogata Y
Jpn J Clin Oncol; 2015 Mar; 45(3):286-90. PubMed ID: 25489005
[TBL] [Abstract][Full Text] [Related]
2. [A case of metastatic colorectal cancer with icterus due to multiple liver metastases treated effectively by FOLFOX plus bevacizumab].
Terasawa T; Koja S; Yasuda K; Fukuda K
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1115-8. PubMed ID: 23986063
[TBL] [Abstract][Full Text] [Related]
3. First description of an uterine perforation potentially imputable to treatment with bevacizumab.
Uguen T; Leconte B; Desgrippes R; Tchoundeu B; Bretagne JF; Manfredi S
Acta Oncol; 2012 Nov; 51(8):1102-4. PubMed ID: 23020310
[No Abstract] [Full Text] [Related]
4. [Two cases of unstable angina in patients treated with bevacizumab].
Okada Y; Okura Y; Takii Y
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1405-8. PubMed ID: 20647738
[TBL] [Abstract][Full Text] [Related]
5. [A case with liver resection of metastasis from rectal cancer after bevacizumab treatment].
Nishida K; Matsuyama T; Masuda D; Hosokawa T; Tokita H; Kakimoto M; Goto H; Yoshimura T; Koshiishi H; Okamura T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2517-9. PubMed ID: 21224625
[TBL] [Abstract][Full Text] [Related]
6. [A case of metastatic rectal cancer in an extremely aged patient successfully treated with mFOLFOX6 plus bevacizumab].
Yokoyama M; Urakawa M; Murakami T; Amano K; Ohsawa T; Okada N; Kumamoto K; Ishibashi K; Ishida H
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2241-3. PubMed ID: 22202342
[TBL] [Abstract][Full Text] [Related]
7. [A case of osteonecrosis of the jaw during treatment by bevacizumab for sigmoid colon cancer].
Sato M; Ono F; Yamamura A; Onochi S
Nihon Shokakibyo Gakkai Zasshi; 2013 Apr; 110(4):655-9. PubMed ID: 23558129
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
[TBL] [Abstract][Full Text] [Related]
9. [Bevacizumab in the treatment of colorectal carcinoma: news from ASCO 2008].
Mansueto G; Longo F
Tumori; 2008; 94(4):suppl 1-14. PubMed ID: 18822711
[No Abstract] [Full Text] [Related]
10. Perirenal hematoma associated with bevacizumab treatment.
Hayashi H; Okamoto I; Nakagawa K
Invest New Drugs; 2012 Apr; 30(2):808-9. PubMed ID: 20865298
[TBL] [Abstract][Full Text] [Related]
11. Onset of segmental colitis associated with diverticulosis after treatment with bevacizumab for metastatic colorectal carcinoma.
Tursi A
J Crohns Colitis; 2012 Aug; 6(7):809-10. PubMed ID: 22658805
[No Abstract] [Full Text] [Related]
12. Perforating dermatosis in a patient receiving bevacizumab.
Vano-Galvan S; Moreno C; Medina J; Pérez-García B; García-López JL; Jaén P
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):972-4. PubMed ID: 19470057
[No Abstract] [Full Text] [Related]
13. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced primary colorectal carcinoma accompanied by liver metastasis in which ileus developed due to marked fibrosis with cicatricial formation in primary colorectal cancer treated by chemotherapy including bevacizumab].
Takanashi K; Katsuki S; Fujita T; Waga E; Shimodate Y; Sasaki K; Someya T; Ohno K; Fujita M
Nihon Shokakibyo Gakkai Zasshi; 2012 May; 109(5):766-73. PubMed ID: 22688102
[TBL] [Abstract][Full Text] [Related]
15. [Ischemic anastomotic bowel perforation during treatment with bevacizumab 10 months after surgery].
Abbrederis K; Kremer M; Schuhmacher C
Chirurg; 2008 Apr; 79(4):351-5. PubMed ID: 17453167
[TBL] [Abstract][Full Text] [Related]
16. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
[TBL] [Abstract][Full Text] [Related]
17. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
18. [A case of rectal cancer with synchronous multiple liver metastases successfully treated with combined chemotherapy of modified FOLFOX6 and bevacizumab].
Tokunou K; Yamamoto T; Toshimitsu H; Kitamura Y; Andou S; Tsushimi K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2626-8. PubMed ID: 21224660
[TBL] [Abstract][Full Text] [Related]
19. Cervical extravasation of bevacizumab.
Dréanic J; Coriat R; Mir O; Perkins G; Boudou-Rouquette P; Brezault C; Dhooge M; Goldwasser F; Chaussade S
Anticancer Drugs; 2013 Apr; 24(4):426-8. PubMed ID: 23262983
[TBL] [Abstract][Full Text] [Related]
20. [Pathologically complete response of multiple liver metastases from rectal cancer treated with mFOLFOX6 plus bevacizumab].
Inoue M; Uehara K; Ishiguro S; Nishio H; Ebata T; Yokoyama Y; Kokuryo T; Tsunoda N; Igami T; Sugawara G; Fukaya M; Nagino M
Nihon Shokakibyo Gakkai Zasshi; 2010 May; 107(5):760-7. PubMed ID: 20460850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
